Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.6K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The prognostic importance of features of myometrial invasion in endometrial endometrioid carcinoma.

Archives of gynecology and obstetrics·2025
Same author

Retrospective cohort study of fluctuations in emergency department visits for nonspecific back and neck pain during the COVID-19 pandemic.

The Journal of international medical research·2024
Same author

"Real-Life" Data of Zanubrutinib in Patients with Waldenström Macroglobulinemia: A Multicenter Retrospective Study.

Acta haematologica·2024
Same author

Asciminib in Advanced-Line Treatment of Chronic Myeloid Leukemia.

European journal of haematology·2024
Same author

Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.

Blood advances·2023
Same author

In Vitro and In Vivo Therapeutic Potential of 6,6'-Dihydroxythiobinupharidine (DTBN) from <i>Nuphar lutea</i> on Cells and K18-<i>hACE2</i> Mice Infected with SARS-CoV-2.

International journal of molecular sciences·2023

Related Experiment Video

Updated: Oct 23, 2025

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.4K

Multiple Myeloma with Foamy Mott Cells.

Karen Nalbandyan1, Daniel Benharroch1, Benzion Samueli1

  • 1Department of Pathology, Soroka University Medical Center, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

Case Reports in Hematology
|August 23, 2021
PubMed
Summary

This study reports a rare case of multiple myeloma presenting with foamy Mott cells, a diagnostic pitfall. Treatment led to significant changes in cell morphology and clonal characteristics over time.

More Related Videos

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.0K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.8K

Related Experiment Videos

Last Updated: Oct 23, 2025

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

4.4K
Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
05:32

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

7.0K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.8K

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • Multiple myeloma is a plasma cell malignancy.
  • Intracytoplasmic immunoglobulin deposits can cause foamy cell morphology.
  • Foamy Mott cells in myeloma are rare and can mimic other conditions.

Observation:

  • A patient with multiple myeloma presented with skeletal pain and lytic lesions.
  • Bone marrow biopsy revealed unusual foamy Mott cells.
  • Morphological and clonal characteristics evolved significantly after treatment with cyclophosphamide, bortezomib, dexamethasone, and lenalidomide.

Findings:

  • The case highlights a morphologic variant of multiple myeloma.
  • Treatment induced dynamic changes in tumor cell appearance.
  • Clonal characteristics, including light chain monotype, fluctuated post-treatment.

Implications:

  • Hematopathologists must recognize foamy Mott cells as a potential variant in multiple myeloma.
  • Awareness of treatment-induced morphologic and clonal shifts is crucial for accurate diagnosis and monitoring.
  • Understanding these fluctuations aids in personalized treatment strategies for multiple myeloma.